Rennie Christopher, Futch Katerina N, Brennan Jane C, Petre Benjamin M, Zaidi Sohail, Turcotte Justin J, Johnson Andrea H, Redziniak Daniel E
Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Tampa, USA.
Orthopedic Research, Anne Arundel Medical Center, Annapolis, USA.
Cureus. 2023 Dec 19;15(12):e50775. doi: 10.7759/cureus.50775. eCollection 2023 Dec.
Background Inhalation anesthesia (IA) and total intravenous anesthesia (TIVA) are common general anesthesia techniques. During rotator cuff repair (RCR), an interscalene block is beneficial for intraoperative and early postoperative pain control. This study aimed to evaluate postoperative outcomes and opioid usage in patients undergoing arthroscopic RCR with an interscalene block and either IA or TIVA. Methodology A retrospective observational study was performed of 478 patients undergoing RCR at a single institution. Demographics, surgical details, intra and postoperative medications, and 90-day outcomes were collected. Univariate and multivariate analyses were performed to evaluate differences between groups. Results In total, 309 (64.6%) patients received IA and 169 (35.3%) received TIVA. Patients receiving IA were more likely to have comorbidities, such as diabetes (p = 0.002), sleep apnea (p = 0.006), gastroesophageal reflux disease (p < 0.001), and hypertension (p < 0.001). After adjusting for differences between groups in the multivariate analysis, patients who received TIVA had significantly shorter surgical time (β = -14.85, p < 0.001) and perioperative time (β = -21.01, p < 0.001) and significantly lower first post-anesthesia care unit Pasero opioid-induced sedation scores (β = -0.022, p = 0.040). Patients who received TIVA were less likely to receive intraoperative narcotics (odds ratio = 0.38; p = 0.031). Conclusions TIVA appears to be a safe and effective anesthetic for patients undergoing arthroscopic RCR. TIVA is a potentially beneficial alternative to IA for this patient population.
吸入麻醉(IA)和全静脉麻醉(TIVA)是常见的全身麻醉技术。在肩袖修复术(RCR)期间,肌间沟阻滞有助于术中及术后早期的疼痛控制。本研究旨在评估接受关节镜下RCR并采用肌间沟阻滞联合IA或TIVA的患者的术后结局及阿片类药物使用情况。
对在单一机构接受RCR的478例患者进行了一项回顾性观察研究。收集了人口统计学资料、手术细节、术中和术后用药情况以及90天的结局。进行单因素和多因素分析以评估组间差异。
总共309例(64.6%)患者接受了IA,169例(35.3%)接受了TIVA。接受IA的患者更有可能患有合并症,如糖尿病(p = 0.002)、睡眠呼吸暂停(p = 0.006)、胃食管反流病(p < 0.001)和高血压(p < 0.001)。在多因素分析中对组间差异进行调整后,接受TIVA的患者手术时间显著缩短(β = -14.85,p < 0.001)和围手术期时间显著缩短(β = -21.01,p < 0.001),且麻醉后护理单元首次Pasero阿片类药物引起的镇静评分显著更低(β = -0.022,p = 0.040)。接受TIVA的患者术中接受麻醉性镇痛药的可能性更小(比值比 = 0.38;p = 0.031)。
TIVA似乎是接受关节镜下RCR患者安全有效的麻醉方法。对于该患者群体而言TIVA是IA潜在的有益替代方法。